the addition of directacting antivirals daas to hepatitis c virus hcv treatment regimens has made treatment more effective and patient management more complexshepherding patients through a full course of hcv therapy requires motivation and involvement on the part of the patient and the physicianindeed physician inexperience and lack of confidence in guiding patients through the challenges of treatment appears to be a primary reason for early discontinuation of therapyamong the many complications of hcv treatment that must be managed efficiently and effectively are depression and other psychiatric disorders hematologic abnormalities including daa and ribavirinassociated anemia and peginterferon alfaassociated neutropenia and thrombocytopenia rash and drug eruptions including telaprevirassociated rash and weight losspractical considerations in management of these common complications are offeredthis article summarizes a presentation by kenneth e sherman md phd at the iasusa live continuing medical education course held in new york in june 2012